논문 상세보기
pp.156-162
저자들은 간전이가 동반된 췌장암 환자에게 erlotinib이 포함된 항암화학요법을 시행하였으며, 치료 기간 중 장벽낭상 기종이 발생한 것을 확인하여 보존적 요법으로 치료하였다. 이후 환자는 동일한 요법으로 항암치료를 지속하였으나, 장 벽낭상기종이 재발하지 않은 것을 경험하였기에 문헌고찰과 더불어 보고하는 바이다.
Pneumatosis cystoides intestinalis (PCI) is an uncommon condition that is characterized by the presence of gas within the bowel wall. We experienced a case of PCI after erlotinib-containing chemotherapy for advanced pancreatic cancer. A 66-year-old woman was admitted to the hospital with intermittent epigastric pain, and she diagnosed with advanced pancreatic cancer accompanied by hepatic metastasis. Combination chemotherapy of gemcitabine and erlotinib was started. PCI occurred about 14 months after start of the chemotherapy but she did not complain of abdominal pain and physical examination showed no evidence of peritoneal irritation sign. Laboratory findings showed no abnormalities. Following conservative treatment for 3 days, no specific symptoms were observed, and abdominal X-ray examination showed reduced abnormal air deposition. Erlotinib-containing chemotherapy was continued and PCI had not recurred.
